This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN), Molina Healthcare (MOH) and Treace Medical Concepts (TMCI)

Tipranks - Tipranks - Tue May 12, 6:52AM CDT

Analysts fell to the sidelines weighing in on Cross Country Healthcare (CCRN), Molina Healthcare (MOH) and Treace Medical Concepts (TMCI) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 55% Off TipRanks

Cross Country Healthcare (CCRN)

Truist Financial analyst Tobey Sommer assigned a Hold rating to Cross Country Healthcare today and set a price target of $13.25. The company’s shares closed last Friday at $13.18.

According to TipRanks.com, Sommer is a 4-star analyst with an average return of 4.1% and a 52.1% success rate. Sommer covers the Industrial Goods sector, focusing on stocks such as Andersen Group, Inc. Class A, Amentum Holdings, Inc., and GFL Environmental. ;'>

Currently, the analyst consensus on Cross Country Healthcare is a Hold with an average price target of $12.38, which is a -5.2% downside from current levels. In a report issued on May 7, Citizens JMP also downgraded the stock to Hold.

See the top stocks recommended by analysts >>

Molina Healthcare (MOH)

In a report released today, Scott Fidel from Goldman Sachs maintained a Hold rating on Molina Healthcare, with a price target of $142.00. The company’s shares closed last Friday at $185.94.

According to TipRanks.com, Fidel is a 4-star analyst with an average return of 8.0% and a 63.4% success rate. Fidel covers the Healthcare sector, focusing on stocks such as Ardent Health Partners, Inc., Alignment Healthcare, and Universal Health. ;'>

Molina Healthcare has an analyst consensus of Hold, with a price target consensus of $168.14, which is a -12.9% downside from current levels. In a report issued on April 27, Truist Financial also maintained a Hold rating on the stock with a $180.00 price target.

Treace Medical Concepts (TMCI)

In a report released today, Richard Newitter from Truist Financial reiterated a Hold rating on Treace Medical Concepts. The company’s shares closed last Friday at $2.01.

According to TipRanks.com, Newitter is a 4-star analyst with an average return of 5.9% and a 44.5% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Irhythm Technologies. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Treace Medical Concepts with a $4.08 average price target, implying a 93.4% upside from current levels. In a report issued on April 30, TipRanks – Anthropic also upgraded the stock to Hold with a $1.50 price target.

Read More on CCRN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).